Hereditary

Our DNA is made up of many genes, each with a specific function. Every gene can exist in different versions, called gene variants. While most variants are harmless and contribute to natural differences between individuals, some variants can increase the risk of developing cancer.

What is Hereditary Cancer Testing?

Certain variants (such as BRCA1 and BRCA2) are strongly linked to specific cancers like breast and ovarian cancer.
Others increase the risk of multiple cancer types because they affect fundamental processes involved in how cells become cancerous.

Having a cancer-related variant does not mean you will definitely develop cancer. It simply means your risk is higher than average. Environmental and lifestyle factors, such as smoking, diet, exercise, and sun exposure, also play a significant role in cancer development.

Overall, it is estimated that 5–10% of cancers are linked to inherited genetic variants.

Hereditary cancer testing looks for these variants to determine whether you have an increased genetic risk. This information can empower individuals to make proactive lifestyle choices, join risk management programmes, and access more frequent screening for earlier detection.

Value of Hereditary cancer Testing

Hereditary cancer testing provides several benefits:

Detects genetic variants that predispose to certain cancers
Access to genetic counselling to explain results and support next steps
Identification of risk management and screening programmes
Supports early cancer detection and risk reduction strategies
Enables both patients and family members to make informed health choices

What Hereditary Cancer Panels do we offer?

Comprehensive Hereditary Cancer Testing Panel (31 genes)
Hereditary Breast Cancer Panel
Hereditary Breast and Gynaecological Cancer Panel
Hereditary Prostate Cancer Panel
Hereditary Colorectal Cancer (including Lynch syndrome) Panel
Hereditary Melanoma Cancer Panel
Hereditary Pancreatic Cancer Panel

Partnering with Your Clinic to Enhance Patient Care

Source Genomics provides clinics and healthcare providers with access to novel biomarker-driven tests across multiple cancer types. Partnering with us will enable access to:

Enhanced delivery of diagnostic testing for your patients, with a focus on personalised care.
Fast turnaround times of test results.
Accredited Quality Standards: All testing is performed in ISO-accredited laboratories with validated workflows and rigorous quality control.

Our accredited hereditary cancer testing services support clinicians in identifying patients with an increased genetic risk, allowing for earlier intervention, targeted screening, and informed family counselling. Get in touch today to find out how you can provide your patients with advanced hereditary cancer testing and clear, actionable results.